Impairment of TNF-receptor-1 signaling but not Fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice

American Journal of Pathology

Volumn 154, Issue 5, 1999, Pages 1417-1422

  Bachmann, Rosilla ^a   Eugster, Hans Pietro ^b   Frei, Karl ^b   Fontana, Adriano ^b   Lassmann, Hans ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; GLYCOPROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; LYMPHOTOXIN; MYELIN; NITRIC OXIDE SYNTHASE; OLIGOPEPTIDE; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; GENE DELETION; KNOCKOUT GENE; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032934534     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65395-3     Document Type: Article

References (28)

1. Gold R, Hartung HP, Lassmann H: T-cell apoptosis in autoimmune diseases:termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci 1997, 20:399-404
2. Bauer J, Bradl M, Hickey WF, Forss-Peter S, Breitschopf H, Linington C, Wekerle H, Lassmann H: T cell apoptosis in acute inflammatory lesions. Destruction of T cells does not depend on antigen recognition. Am J Pathol 1998, 153:715-724
3. Nagata S, Golstein P: The Fas death factor. Science 1995, 267:1449-1456
4. Tartaglia LA, Ayres TM, Wong GH: A novel domain within the 55kd TNF receptor signals cell death. Cell 1993, 74:845-853
5. Sun D, Qin Y, Chluba I, Epplen IT, Wekerle H: Suppression of experimental autoimmune encephalomyelitis by cytotoxic T-T-cell interactions. Nature 1988, 332:843-845
6. Zettl UK, Mix E, Zielase J, Stangel M, Hartung HP, Gold R: Apoptosis of myelin-reactive T-cells induced by reactive oxygen and nitrogen intermediates in vitro. Cell Immunol 1997, 178:1-8
7. Mendel I, Kerlero de Rosbo N, Ben-Nun A: A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specifity and T-cell receptor V β expression of encephalitogenic T cells. Eur J Immunol 1995, 25:1951-1959
8. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV, Lassmann H: Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994, 71:219-225
9. Eugster HP, Frei K, Bachmann R, Bluethmann H, Lassmann H, Fontana A: Severity of symptoms and demyelination depends on expression of LTa and TNFR1 in MOG induced EAE. Eur J Immunol 1999, 29:626-632
10. Malipiero U, Frei K, Spanaus KS, Agresti C, Lassmann H, Hahne M, Tschopp J, Eugster HP, Fontana A: Myelin oligodendrocyte glycoprotein induced encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. Eur J Immunol 1997, 27:3151-3160
11. Sahrbacher UC, Lechner F, Eugster HP, Frei K, Lassmann H, Fontana A: Mice with and inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur J Immunol 1997, 28:1332-1338
12. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson, TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995, 270:1189-1192
13. Pender MP, Nguyen KB, McCombe PA, Kerr JFR: Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 1991, 104:81-87
14. Schmied M, Breitschopf H, Gold R, Zischler H, Rothe G, Wekerle H, Lassmann H: Apoptosis of T-lymphocytes in experimental autoimmune encephalomyelitis: evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 1993, 143:446-452
15. Griffith TS, Ferguson TA: The role of FasL-induced apoptosis in immune privilege. Immunol Today 1997, 18:203-225
16. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP: Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 1996, 184:2361-2370
17. Graeber MB, Streit WJ, Kiefer R, Schoen SW, Kreutzberg GW: New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury. J Neuroimmunol 1990, 27:121-132
18. Pinckard JK, Sheehan KC, Schreiber RD: Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocomplexes on intact cells. J Biol Chem 1997, 272:10748-10789
19. Weiss T, Grell M, Siemiensky K, Mühlenbeck F, Dürkop H, Pfitzenmaier K, Scheurich P, Wajant H: TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2, and is specific for TNFR60. J Immunol 1998, 161:3136-3142
20. Weishaupt A, Gold R, Gaupp S, Giegerich G, Hartung HP, Tokya KV: Antigen therapy eliminates T-cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2. Proc Natl Acad Sci USA 1997, 94:1338-1343
21. Whitaker JN, Lisak RP, Bashir RM, Fitch OH, Seyer JM, Krance R, Lawrence JA, Ch'ien LT, O'Sullivan P: Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann Neurol 1980, 7:58-64
22. Braun MY, Lowin B, French L, Acha-Orbea H, Tschopp J: Cytotoxic T cells deficient in both functional fas ligand, and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J Exp Med 1996, 183:657-661
23. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MSS, Flawell RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 1995, 267:2000-2002
24. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H: Mice lacking the tumor necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Lysteria monocytogenes. Nature 1993, 364:798-802
25. Erickson SL, Kikly SF de K, Carver MK, Pitts MS, Gillett N, Sheehan KC, Schreiber RD, Goeddel DV, Moore MW: Decreased sensitivity to tumour necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 1994, 372:560-563
26. Eugster HP, Muller M, Karrer U, Car BD, Schnyder B, Eng VM, Woerly HM, Le Hir M, di Padova F, Auget M, Zinkernagel R, Bluethmann H, Ryffel B: Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double-deficient mice, Int Immunol 1996, 8: 23-36
27. Garcia I, Miyazaki V, Araki M, Lucas R, Grau GE, Milon G, Belkaid Y, Montixi C, Lesslauer W: Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Lysteria monocytogenes and Leishmania major infections. Eur J Immunol 1995, 25: 2401-2407
28. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K: Altered response to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995, 81:641-650